Product Name | 4'-DMA-7,8-DHF (Eutropoflavin) |
Other Name | 4'-Dimethylamino-7,8-dihydroxyflavone Hydrobromide |
CAS No. | 1205548-00-0 |
Appearance | yellow powder
|
Purity | 99% |
Storage | Room temperature |
MF | C17H15NO4 |
Shelf Life | 2 years |
| Grade | Enterprise standard |
4'-Dimethylamino 7,8 Dihydroxyflavone (4’-DMA-7,8-DHF/Eutropoflavin) is a nootropic compound derivative of the naturally occurring flavone 7,8 Dihydroxyflavone (7,8 DHF). 4’-DMA-7,8-DHF differs from 7,8-DHF by the addition of a dimethylamino group off the 4 position on the flavone base structure. A dimethyl amino group consists of a nitrogen atom with two methyl groups.
Advanced Neuroprotection
4'-DMA-7,8-DHF Free Base is a cutting-edge compound known for its neuroprotective properties. By activating TrkB receptors, this molecule mimics BDNF, a crucial protein in brain health, promoting neuronal growth and repair. This mechanism is significant in addressing neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Cognitive Function Enhancement
With its ability to cross the blood-brain barrier, 4'-DMA-7,8-DHF serves as a potent cognitive enhancer. It is ideal for inclusion in supplements aimed at boosting memory, learning capabilities, and overall cognitive performance, making it valuable for both therapeutic and wellness applications.
Research and Development Edge
As a free base form, it offers versatility in pharmaceutical formulations and research settings, providing a foundation for the creation of innovative therapies targeting the central nervous system. Our commitment to quality ensures this product meets rigorous industry standards, paving the way for advancements in cognitive health solutions.
1. Pharmaceutical Development
4'-DMA-7,8-DHF is gaining attention in pharmaceutical research due to its promising neuroprotective capabilities. As a selective TrkB receptor agonist, it mimics the activity of brain-derived neurotrophic factor (BDNF), playing a pivotal role in neuronal survival and maintenance. This property makes it a valuable candidate for developing therapeutic agents targeting neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Its capacity to enhance synaptic plasticity and support neuronal health positions it as a critical component in drugs aimed at improving or stabilizing cognitive function in patients with neurodegenerative conditions.
2. Nutritional and Cognitive Supplements
In the nutrition and wellness sector, 4'-DMA-7,8-DHF is leveraged as a potent cognitive enhancer. Its ability to traverse the blood-brain barrier efficiently allows it to directly influence brain function, making it an ideal ingredient in nootropic supplements. These supplements are designed to enhance memory, learning, and concentration, catering to both aging populations seeking to mitigate cognitive decline and younger individuals aiming to boost mental performance. The compound’s natural origin and targeted action make it an attractive option for formulating safe and effective brain health products.
3. Scientific Research and Biotechnology
Beyond its therapeutic and supplement applications, 4'-DMA-7,8-DHF serves as a crucial tool in scientific research and biotechnological innovations. It is utilized to explore TrkB receptor pathways and BDNF-related mechanisms, contributing to a deeper understanding of neural biology and brain health. In research settings, this compound aids in elucidating the molecular underpinnings of cognitive processes and neurological diseases, driving advancements in both diagnostic and therapeutic technologies. Its role in research not only enhances scientific knowledge but also facilitates the development of novel strategies for treating and understanding various cognitive and psychiatric disorders.
